Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114881 · ClinicalTrials.gov registry record
Urban Environmental Factors and Childhood Asthma
A clinical trial of Asthma and Allergy, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 560
- Enrollment target
- 4
- Study locations
NCT00114881 is a study of Asthma and Allergy that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 560 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (64% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT00114881, a study of Asthma and Allergy, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 560 participants
- Enrollment target
- 4
- Study locations
Study Summary
Minority children who grow up in poor urban neighborhoods have the highest rates of asthma, and also experience greater morbidity from acute exacerbations of this disease. The aim of this study is to further identify environmental factors unique to the inner city that affect immune development and the expression of wheezing, atopy and asthma for purposes of identifying new strategies for asthma prevention.
Study Locations (4)
Maryland
- Pediatric Clinical Research Unit, Johns Hopkins University - Baltimore
Massachusetts
- Boston Medical Center - Boston
Missouri
- Saint Louis Children's Hospital - St Louis
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 560 participants |
| Start Date | 2005-02-02 |
| Est. Completion | 2024-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00114881
The ClinicalTrials.gov registry entry for NCT00114881 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 560 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (64% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT00114881 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Maryland, Massachusetts, Missouri.
Frequently Asked Questions
What is clinical trial NCT00114881 about?
NCT00114881 is a clinical study titled "Urban Environmental Factors and Childhood Asthma". Minority children who grow up in poor urban neighborhoods have the highest rates of asthma, and also experience greater morbidity from acute exacerbations of this disease. The aim of this study is to further identify environmental factors unique to the inner city that affect immune development and t...
What is the current status of trial NCT00114881?
This trial is currently completed. The enrollment target is 560 participants. The study started on 2005-02-02. Estimated completion is 2024-08-31.
What conditions does trial NCT00114881 study?
This clinical trial studies the following conditions: Asthma, Allergy.
Who is sponsoring clinical trial NCT00114881?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00114881 being conducted?
This trial has 4 study locations across Maryland, Massachusetts, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.